INS and type 2 diabetes mellitus: Moreover, individuals with Type 2 diabetes randomized to pioglitazone experienced improvements in insulin sensitivity in conjunction with increases in NP bioactivity, as determined by the expression of NP receptors in adipose tissue [46].